AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Search Results for: "National Institute of Allergy and Infectious Diseases"

NIH’s Dr. Carl Dieffenbach Shares Science Highlight from Second Day of AIDS 2014

fauci_special_session

The second day of the 20th International AIDS Conference (AIDS 2014) in Melbourne, Australia was filled with scientific findings shared by researchers from around the world. We caught up again with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), and asked him to reflect…

NIH’s Dr. Carl Dieffenbach Looks Ahead to Key Topics to be Explored at AIDS 2014

Carl Dieffenbach Day 1 AIDS 2014

As the 20th International AIDS Conference (AIDS 2014) opened in Melbourne, Australia on Sunday, July 20, 2014, we had the chance to speak with Dr. Carl Dieffenbach. He’s the Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). During our brief conversation, Dr. Dieffenbach reflects on the conference theme, “Stepping…

Dr. Fauci Reflects on HIV Colleagues Lost in Flight MH-17

Dr. Anthony Fauci

On Sunday, July 20, 2014, just before the opening of the 20th International AIDS Conference (AIDS 2014) in Australia, we had the opportunity to speak with Dr. Anthony Fauci, Director of NIH’s National Institute of Allergy and Infectious Diseases (NIAID) about the Malaysia Airlines Flight 17. Among those lost was world-renowned AIDS researcher Dr. Joep…

NIH Seeks Applications for HIV and Viral Hepatitis Co-Infection Research Funding

Ronald Valdiserri

The National Institutes of Health (NIH) recently released two funding opportunity announcements (FOAs) to support multidisciplinary studies of HIV and viral hepatitis co-infection. The opportunities were issued under NIH’s R01 or Research Project Grant program and R21 or Exploratory/Developmental Research Grant program. NIH notes that the FOAs were informed by priority areas in the Action…

NIH’s Dr. Carl Dieffenbach Shares Highlights from CROI 2014 – March 4

Carl Dieffenbach at CROI

Yesterday, March 4, was the first full day of the 2014 Conference on Retroviruses and Opportunistic Infections (CROI)  in Boston. Over 4,000 HIV/AIDS research leaders from 85 countries are gathered at the annual scientific meeting discussing their work to understand, prevent, and treat HIV/AIDS and related infectious diseases. We’ve invited our colleague Dr. Carl Dieffenbach to…

MEDIA AVAILABILITY: Durable End to AIDS Will Require HIV Vaccine Development

NIAID

Recent Scientific Advances Offer Promising Areas for Further Exploration   WHAT: Broader global access to lifesaving antiretroviral therapies and wider implementation of proven HIV prevention strategies could potentially control and perhaps end the HIV/AIDS pandemic. However, a safe and at least moderately effective HIV vaccine is needed to reach this goal more expeditiously and in…

NIH Names Leadership, Research Units for Restructured HIV/AIDS Clinical Trials Networks

nih logo

The National Institute of Allergy and Infectious Diseases (NIAID) has selected the principal investigators and clinical trials units (CTUs) that will lead and conduct the research of the five restructured HIV/AIDS clinical trials networks through 2021. The new structure is designed to create a broader, more flexible and more collaborative approach to the networks’ research priorities, which…

Key Federal World AIDS Day Speeches

World AIDS Day logo

The week of World AIDS Day is always an important and busy time for the HIV community. Our partners work especially hard to lend visibility to HIV awareness and to educate people we may not reach the rest of the year. We end this week by showcasing several key voices in the dialogue for HIV/AIDS…